“We’re trying to design smarter cells," Stanley Qi says. Using the CRISPR gene-editing method, Qi gave certain immune cells a "homing beacon" to zero in on leukemia. His research could one day lead to treatments for Parkinson’s and other cancers.http://stanford.io/2FaFV4s
0 replies
26 retweets
60 likes
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.